Scarica l'app Stockscreener
1.6868
58.29%
-2.2932
Prelude Therapeutics Inc Azioni (PRLD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | 4.00 | 3.00 | - |
Operating Expenses
|
6.97%
32.19
|
34.61 | 37.83 | 37.38 | 37.16 |
| Operating Income/Loss |
6.97%
-32.19
|
-34.61 | -33.83 | -34.38 | -37.16 |
| Income/Loss From Continuing Operations Before Tax |
2.66%
-31.23
|
-32.09 | -28.73 | 3.00 | -34.74 |
| Income/Loss From Continuing Operations After Tax |
2.66%
-31.23
|
-32.09 | -28.73 | -32.27 | -34.74 |
|
Net Income/Loss
|
2.66%
-31.23
|
-32.09 | -28.73 | -32.27 | -34.74 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.01%
75.99
|
75.99 | 0.0209 | 75.86 | 75.76 |
| Diluted Average Shares |
0.01%
75.99
|
75.99 | 0.0209 | 75.86 | 75.76 |
| Basic Earnings Per Share |
2.38%
-0.41
|
-0.42 | -0.38 | -0.43 | -0.46 |
| Diluted Earnings Per Share |
2.38%
-0.41
|
-0.42 | -0.38 | -0.43 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.17%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):